NCT03406299 2026-04-09
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
Clinical Trials
87 trialsNCT07319767 2026-04-06
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Shanghai Zhongshan Hospital
Completed
NCT02829918 2026-03-11
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT03785873 2026-02-13
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Completed
NCT05254847 2026-01-20
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC
Fudan University
Phase 2 Completed
NCT04896931 2026-01-07
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Completed
NCT07252570 2025-11-26
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
Centre Hospitalier Universitaire de Nice
Completed
NCT03044587 2025-10-01
NIFE
AIO-Studien-gGmbH
Phase 2 Completed
NCT05052099 2025-09-29
COMBATBIL
University Hospital, Essen
Phase 1/2 Completed
NCT05429203 2025-09-15
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
Stanford University
Phase NA Completed
NCT05044065 2025-08-27
PREV-Ex
Karolinska Institutet
Phase NA Completed
NCT04871321 2025-08-26
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
CHA University
Completed
NCT03639935 2025-06-03
Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT06960733 2025-05-07
Comparison Between Winged Versus Traditional Plastic Stents for Biliary Drainage
University of Leipzig
Phase NA Completed
NCT05239169 2025-05-01
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT04566614 2025-04-06
PREVAILctDNA
Royal Marsden NHS Foundation Trust
Completed
NCT03673072 2024-11-12
GAIN
Krankenhaus Nordwest
Phase 3 Completed
NCT04595058 2024-04-18
BAMPI
Hospital Universitari de Bellvitge
Phase NA Completed
NCT04720131 2024-01-30
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
Beijing Friendship Hospital
Phase 2 Completed
NCT06222619 2024-01-25
Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar Cholangiocarcinoma
Seoul National University Hospital
Completed
NCT03796429 2023-11-29
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT04722133 2023-10-11
Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy
Yonsei University
Phase 2 Completed
NCT02866383 2023-09-22
CheckPAC
Herlev Hospital
Phase 2 Completed
NCT05190575 2023-07-27
TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT02351765 2023-05-17
ABC-08
The Christie NHS Foundation Trust
Phase 1 Completed
NCT05028439 2023-02-21
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT03079427 2022-12-06
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
Asan Medical Center
Phase 2 Completed
NCT02784353 2022-11-17
PReHeBP
Asan Medical Center
Phase NA Completed
NCT03101566 2022-10-28
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT02489422 2022-10-14
PRO-YOU
Wake Forest University Health Sciences
Phase NA Completed
NCT03524508 2022-08-24
Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer
Asan Medical Center
Phase 2 Completed
NCT04776837 2022-08-04
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Completed
NCT03110328 2022-06-15
Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes
Samsung Medical Center
Phase 2 Completed
NCT01657383 2022-04-27
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
Wake Forest University Health Sciences
Completed
NCT03162510 2022-04-07
SOLAR
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT02703714 2022-01-25
Pembrolizumab and GM-CSF in Biliary Cancer
University of California, San Francisco
Phase 2 Completed
NCT03486678 2021-10-28
SHR-1210 in Combination With GEMOX in Patients With Advanced BTC
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT03093870 2021-08-03
TreeTopp
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT04656249 2021-06-04
LENABC
Peking Union Medical College Hospital
Phase 2 Completed
NCT04642664 2021-06-03
ACABC
Peking Union Medical College Hospital
Phase 2 Completed
NCT04801719 2021-03-17
Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis
Brno University Hospital
Phase NA Completed
NCT03778593 2021-02-04
FOLFIRINOX for 2nd-line Treatment of BTC
Dong-A University Hospital
Phase 2 Completed
NCT03613168 2021-01-05
BILHER
Asan Medical Center
Phase 2 Completed
NCT03504293 2020-12-22
The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions
Sahlgrenska University Hospital
Completed
NCT03231176 2020-11-19
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
ASLAN Pharmaceuticals
Phase 2 Completed
NCT01099631 2020-07-20
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT03411200 2020-07-14
PACE-Mobil
Herlev and Gentofte Hospital
Phase NA Completed
NCT00948935 2020-03-11
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01926236 2020-01-28
ABC06
The Christie NHS Foundation Trust
Phase 3 Completed
NCT02773459 2019-09-30
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Seoul National University Hospital
Phase 1/2 Completed